CD69 and neoplasm: Similar findings were observed in the tumour tissue, wherein post-CROSS CRT the percentages of tumour-infiltrating CD3+CD8+CD69+ T cells were significantly higher compared with treatment-naïve tumour tissue (63.3 ± 10.0 vs. 90.08 ± 3.0%, p = 0.04), (Fig. 5).